Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Published Online
on February 28, 2005

Hypertension. 2005
Published online before print February 28, 2005, doi: 10.1161/01.HYP.0000159192.93968.8f
A more recent version of this article appeared on May 1, 2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
45/5/840    most recent
01.HYP.0000159192.93968.8fv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carey, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carey, R. M.
Related Collections
Right arrow ACE/Angiotension receptors

Submitted on November 17, 2004
Revised on December 20, 2004

Cardiovascular and Renal Regulation by the Angiotensin Type 2 Receptor. The AT2 Receptor Comes of Age

Robert M. Carey*

From the Division of Endocrinology and Metabolism, Department of Medicine, University of Virginia School of Medicine, Charlottesville.

* To whom correspondence should be addressed. E-mail: rmc4c{at}virginia.edu.




This article has been cited by other articles:


Home page
 Exp PhysiolHome page
A. P. Mecca, T. E. O'Connor, M. J. Katovich, and C. Sumners
Candesartan pretreatment is cerebroprotective in a rat model of endothelin-1-induced middle cerebral artery occlusion
Exp Physiol, August 1, 2009; 94(8): 937 - 946.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
L. Yvan-Charvet, F. Massiera, N. Lamande, G. Ailhaud, M. Teboul, N. Moustaid-Moussa, J.-M. Gasc, and A. Quignard-Boulange
Deficiency of Angiotensin Type 2 Receptor Rescues Obesity But Not Hypertension Induced by Overexpression of Angiotensinogen in Adipose Tissue
Endocrinology, March 1, 2009; 150(3): 1421 - 1428.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
B. Ulmasov, Z. Xu, L. H. Tetri, T. Inagami, and B. A. Neuschwander-Tetri
Protective role of angiotensin II type 2 receptor signaling in a mouse model of pancreatic fibrosis
Am J Physiol Gastrointest Liver Physiol, February 1, 2009; 296(2): G284 - G294.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
N. E. Hoch, T. J. Guzik, W. Chen, T. Deans, S. A. Maalouf, P. Gratze, C. Weyand, and D. G. Harrison
Regulation of T-cell function by endogenously produced angiotensin II
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2009; 296(2): R208 - R216.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
L. E. Yang, M. B. Sandberg, A. D. Can, K. Pihakaski-Maunsbach, and A. A. McDonough
Effects of dietary salt on renal Na+ transporter subcellular distribution, abundance, and phosphorylation status
Am J Physiol Renal Physiol, October 1, 2008; 295(4): F1003 - F1016.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
H. Ohtsu, S. Higuchi, H. Shirai, K. Eguchi, H. Suzuki, A. Hinoki, E. Brailoiu, A. D. Eckhart, G. D. Frank, and S. Eguchi
Central Role of Gq in the Hypertrophic Signal Transduction of Angiotensin II in Vascular Smooth Muscle Cells
Endocrinology, July 1, 2008; 149(7): 3569 - 3575.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
K. Thieme, D. M. N. Eguti, M. Mello-Aires, and M. Oliveira-Souza
The effect of angiotensin II on intracellular pH is mediated by AT1 receptor translocation
Am J Physiol Cell Physiol, July 1, 2008; 295(1): C138 - C145.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. H. Lee, S. Xia, and L. Ragolia
Upregulation of AT2 receptor and iNOS impairs angiotensin II-induced contraction without endothelium influence in young normotensive diabetic rats
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2008; 295(1): R144 - R154.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
S. Eguchi
Triple Twist Theory of Rho Inhibition by the Angiotensin II Type 2 Receptor
Circ. Res., May 23, 2008; 102(10): 1143 - 1145.
[Full Text] [PDF]

Home page
 Cardiovasc ResHome page
Q. Zhang, F. He, R. Kuruba, X. Gao, A. Wilson, J. Li, T. R. Billiar, B. R. Pitt, W. Xie, and S. Li
FXR-mediated regulation of angiotensin type 2 receptor expression in vascular smooth muscle cells
Cardiovasc Res, February 1, 2008; 77(3): 560 - 569.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
H. Nakashima, G. D. Frank, H. Shirai, A. Hinoki, S. Higuchi, H. Ohtsu, K. Eguchi, A. Sanjay, M. E. Reyland, P. J. Dempsey, et al.
Novel Role of Protein Kinase C-{delta} Tyr311 Phosphorylation in Vascular Smooth Muscle Cell Hypertrophy by Angiotensin II
Hypertension, February 1, 2008; 51(2): 232 - 238.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
C. Roberge, A. C. Carpentier, M.-F. Langlois, J.-P. Baillargeon, J.-L. Ardilouze, P. Maheux, and N. Gallo-Payet
Adrenocortical dysregulation as a major player in insulin resistance and onset of obesity
Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1465 - E1478.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
Kai Chen, D. C. Merrill, and J. C. Rose
The Importance of Angiotensin II Subtype Receptors for Blood Pressure Control During Mouse Pregnancy
Reproductive Sciences, October 1, 2007; 14(7): 694 - 704.
[Abstract] [PDF]

Home page
 HypertensionHome page
M. C. Chappell
Emerging Evidence for a Functional Angiotensin-Converting Enzyme 2-Angiotensin-(1-7)-Mas Receptor Axis: More Than Regulation of Blood Pressure?
Hypertension, October 1, 2007; 50(4): 596 - 599.
[Full Text] [PDF]

Home page
 StrokeHome page
J. S. Smeda and J. J. McGuire
Effects of Poststroke Losartan Versus Captopril Treatment on Myogenic and Endothelial Function in the Cerebrovasculature of SHRsp
Stroke, May 1, 2007; 38(5): 1590 - 1596.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
L. Oliveira, C. M. Costa-Neto, C. R. Nakaie, S. Schreier, S. I. Shimuta, and A. C. M. Paiva
The Angiotensin II AT1 Receptor Structure-Activity Correlations in the Light of Rhodopsin Structure
Physiol Rev, April 1, 2007; 87(2): 565 - 592.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
I. Hernandez Schulman, M.-S. Zhou, and L. Raij
Cross-Talk Between Angiotensin II Receptor Types 1 and 2: Potential Role in Vascular Remodeling in Humans
Hypertension, February 1, 2007; 49(2): 270 - 271.
[Full Text] [PDF]

Home page
 HypertensionHome page
L. J. Salomone, N. L. Howell, H. E. McGrath, B. A. Kemp, S. R. Keller, J. J. Gildea, R. A. Felder, and R. M. Carey
Intrarenal Dopamine D1-Like Receptor Stimulation Induces Natriuresis via an Angiotensin Type-2 Receptor Mechanism
Hypertension, January 1, 2007; 49(1): 155 - 161.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
H. Suzuki, K. Eguchi, H. Ohtsu, S. Higuchi, S. Dhobale, G. D. Frank, E. D. Motley, and S. Eguchi
Activation of Endothelial Nitric Oxide Synthase by the Angiotensin II Type 1 Receptor
Endocrinology, December 1, 2006; 147(12): 5914 - 5920.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
R. M. Carey and J. Park
Role of Angiotensin Type 2 Receptors in Vasodilation of Resistance and Capacitance Vessels
Hypertension, November 1, 2006; 48(5): 824 - 825.
[Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M.-Z. Zhang, B. Yao, H.-F. Cheng, S.-W. Wang, T. Inagami, and R. C. Harris
Renal cortical cyclooxygenase 2 expression is differentially regulated by angiotensin II AT1 and AT2 receptors
PNAS, October 24, 2006; 103(43): 16045 - 16050.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
H. Beaudry, L. Gendron, M.-O. Guimond, M. D. Payet, and N. Gallo-Payet
Involvement of Protein Kinase C{alpha} (PKC{alpha}) in the Early Action of Angiotensin II Type 2 (AT2) Effects on Neurite Outgrowth in NG108-15 Cells: AT2-Receptor Inhibits PKC{alpha} and p21ras Activity
Endocrinology, September 1, 2006; 147(9): 4263 - 4272.
[Abstract] [Full Text] [PDF]

Home page
 Journal of Renin-Angiotensin-Aldosterone SystemHome page
N. Poulter, A. D Hughes, B. Williams, A. J. Brady, and G. McInnes
Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers: A mini-symposium held at the British Hypertension Society Meeting, September 2005
Journal of Renin-Angiotensin-Aldosterone System, June 1, 2006; 7(2): 104 - 121.
[PDF]

Home page
 HypertensionHome page
S. H. Padia, N. L. Howell, H. M. Siragy, and R. M. Carey
Renal Angiotensin Type 2 Receptors Mediate Natriuresis Via Angiotensin III in the Angiotensin II Type 1 Receptor-Blocked Rat
Hypertension, March 1, 2006; 47(3): 537 - 544.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
A. D'Amore, M. J. Black, and W. G. Thomas
The Angiotensin II Type 2 Receptor Causes Constitutive Growth of Cardiomyocytes and Does Not Antagonize Angiotensin II Type 1 Receptor-Mediated Hypertrophy
Hypertension, December 1, 2005; 46(6): 1347 - 1354.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
T. L. Reudelhuber
The Continuing Saga of the AT2 Receptor: A Case of the Good, the Bad, and the Innocuous
Hypertension, December 1, 2005; 46(6): 1261 - 1262.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
A. P. V. Dantas and K. Sandberg
Regulation of ACE2 and ANG-(1-7) in the aorta: new insights into the renin-angiotensin system in the control of vascular function
Am J Physiol Heart Circ Physiol, September 1, 2005; 289(3): H980 - H981.
[Full Text] [PDF]


Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.